Navigation Links
Thomson Reuters Cortellis Drives Drug Discovery and Development With Powerful New Web Services
Date:2/28/2012

PHILADELPHIA, and LONDON, Feb. 28, 2012 /PRNewswire/ -- Thomson Reuters announced the availability of Cortellis for Informatics, a new capability that speeds access to critical life sciences research and development information found on its premiere life sciences platform, Thomson Reuters Cortellis.

Cortellis for Informatics uses sophisticated application programming interfaces (APIs) to enhance the research and development process by delivering real-time access to powerful information and tools for biopharmaceutical competitive intelligence, drug pipeline, and drug research and development.

Each API integrates Thomson Reuters data with proprietary content and public information sources into a comprehensive view that is customized to meet the needs of a company, team or individual researcher. With Cortellis for Informatics, data can be shared in a number of ways, including dashboards, custom reports and alerts, and intranet and mobile applications.

"We worked closely with Thomson Reuters during their development and testing phases, and I am delighted to say that the Cortellis APIs exceed my expectations and allow us to take advantage of Thomson Reuters content in the systems that drive our business," said Dr. William Hayes, director of Decision Support at Biogen Idec.

"For life sciences professionals, Cortellis for Informatics is a significant step forward," said Wendy Hamilton, senior vice president at Thomson Reuters. "The advanced options for obtaining information give customers access to our content beyond Cortellis' highly intuitive web portal. Information can now be incorporated directly on the user's preferred systems, customized to their needs, creating additional opportunities for integration across the entire organization."

Cortellis for Informatics streamlines information sharing across all levels of the organization. Instead of using multiple systems to manage workflows, researchers access up-to-the-minute news in the office, in meetings or at the bench. This ability to deploy high-quality Thomson Reuters information across the whole company in real time within internal systems provides greater opportunities for collaboration in the scientific search and discovery process.

Cortellis for Informatics provides web services for investigational drugs, drug targets, ontologies, patents, clinical trials and analytics.

For more information on Cortellis, visit cortellis.thomsonreuters.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
2. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
3. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
4. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
5. Thomson Reuters Commemorates World IP Week with Series of Strategic Intellectual Property Seminars Across the U.S.
6. Thomson Reuters Examines Highly Cited Research in Bioterrorism
7. Thomson Reuters Makes Disease Briefing on Influenza Covering H1N1 (Swine Flu) Publicly Available
8. Brazils Scientific Research On The Rise, Thomson Reuters Study Finds
9. Thomson Reuters Partners With Sagient Research
10. Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
11. Thomson Reuters Joins the InChI Trust
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):